DANIEL MAYS: Open Payments
NPI 1003248444 · CLINTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 20 payments from 11 companies in 2025. Trend: 2023 $687 · 2024 $665 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $98 |
| Boston Scientific Corporation | 2 | $66 |
| Dexcom, Inc. | 3 | $65 |
| Amgen Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Dexcom G6 Transmitter, Ozempic, WaveWriter Alpha Prime 16, Rybelsus, VOQUEZNA, MOUNJARO, CAMZYOS, ELIQUIS.
Industry payments across TN — which companies pay providers there.
